Osteopontin and thrombospondin-1 play opposite roles in promoting tumor aggressiveness of primary resected non-small cell lung cancer

Prognostic information of serial plasma osteopontin measurement in radiotherapy of non-small-cell lung cancer

(2014) Christian Ostheimer et al.   BMC CANCER

Cancer statistics, 2014

(2014) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Osteopontin is a prognostic biomarker in non-small cell lung cancer

(2013) Ane Kongsgaard Rud et al.   BMC CANCER

Matricellular proteins: priming the tumour microenvironment for cancer development and metastasis

(2013) G S Wong et al.   BRITISH JOURNAL OF CANCER

Detection of Circulating Tumor Cells Harboring a Unique ALK Rearrangement in ALK-Positive Non–Small-Cell Lung Cancer

(2013) Emma Pailler et al.   JOURNAL OF CLINICAL ONCOLOGY

ERCC1 Isoform Expression and DNA Repair in Non–Small-Cell Lung Cancer

(2013) Luc Friboulet et al.   NEW ENGLAND JOURNAL OF MEDICINE

Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment

(2012) Douglas Hanahan et al.   CANCER CELL

Tumor Microenvironment Complexity: Emerging Roles in Cancer Therapy

(2012) M. A. Swartz et al.   CANCER RESEARCH

Serum Level of Osteopontin as a Prognostic Factor in Patients Who Underwent Surgical Resection for Non–Small-Cell Lung Cancer

(2012) Masaru Takenaka et al.   Clinical Lung Cancer

Recurrence Dynamics for Non–Small-Cell Lung Cancer: Effect of Surgery on the Development of Metastases

(2012) Romano Demicheli et al.   Journal of Thoracic Oncology

Osteopontin: a potentially important therapeutic target in cancer

(2011) Mansoor Ahmed et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma

(2011) William D. Travis et al.   Journal of Thoracic Oncology

A Perspective on Cancer Cell Metastasis

(2011) C. L. Chaffer et al.   SCIENCE

Pre- and post-translational regulation of osteopontin in cancer

(2011) Pieter H. Anborgh et al.   Journal of Cell Communication and Signaling

Osteopontin is a marker for cancer aggressiveness and patient survival

(2010) G F Weber et al.   BRITISH JOURNAL OF CANCER

Matricellular proteins: from homeostasis to inflammation, cancer, and metastasis

(2010) Claudia Chiodoni et al.   CANCER AND METASTASIS REVIEWS

Role of the metastasis-promoting protein osteopontin in the tumour microenvironment

(2010) Pieter H. Anborgh et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Reduction of Elevated Plasma Osteopontin Levels With Resection of Non–Small-Cell Lung Cancer

(2010) Justin D. Blasberg et al.   JOURNAL OF CLINICAL ONCOLOGY

Serum Osteopontin Levels are Highly Prognostic for Survival in Advanced Non-small Cell Lung Cancer: Results from JMTO LC 0004

(2010) Shun-Ichi Isa et al.   Journal of Thoracic Oncology

Adjuvant chemotherapy, with or without postoperative radiotherapy, in operable non-small-cell lung cancer: two meta-analyses of individual patient data

(2010)   LANCET

Thrombospondin 1 Promotes Tumor Macrophage Recruitment and Enhances Tumor Cell Cytotoxicity of Differentiated U937 Cells

(2008) G. Martin-Manso et al.   CANCER RESEARCH

Thrombospondins: from structure to therapeutics

(2008) D. D. Roberts   CELLULAR AND MOLECULAR LIFE SCIENCES

Thrombospondins: from structure to therapeutics

(2008) S. Kazerounian et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Role of osteopontin in cellular signaling and metastatic phenotype

(2008) Mohamed et al.   Frontiers in Bioscience-Landmark

Lower Osteopontin Plasma Levels Are Associated With Superior Outcomes in Advanced Non–Small-Cell Lung Cancer Patients Receiving Platinum-Based Chemotherapy: SWOG Study S0003

(2008) Philip C. Mack et al.   JOURNAL OF CLINICAL ONCOLOGY

Lung Adjuvant Cisplatin Evaluation: A Pooled Analysis by the LACE Collaborative Group

(2008) Jean-Pierre Pignon et al.   JOURNAL OF CLINICAL ONCOLOGY